Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Total 13F shares
-
111,812,148
-
Share change
-
+2,908,151
-
Total reported value
-
$18,955,218,376
-
Put/Call ratio
-
86%
-
Price per share
-
$169.52
-
Number of holders
-
389
-
Value change
-
+$508,317,710
-
Number of buys
-
190
-
Number of sells
-
166
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q2 2021
As of 30 Jun 2021 ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) had 389 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 111,812,148 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Dodge & Cox, STATE STREET CORP, JPMORGAN CHASE & CO, and MORGAN STANLEY.
This table shows 393 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.